TRL1068, a human monoclonal antibody

DRUG2 trials

Sponsors

Trellis Bioscience LLC

Conditions

Healthy VolunteerProsthetic Joint Infection

Phase 1

Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections

CompletedNCT04763759

Trellis Bioscience LLCProsthetic Joint Infection

Start: 2021-02-08End: 2024-03-13Updated: 2024-11-21

Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers

Not yet recruitingNCT07644195

Trellis Bioscience LLCHealthy Volunteer

Start: 2026-10-01End: 2026-12-01Target: 14Updated: 2026-06-12

Related Papers

Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip

Antimicrobial Agents and Chemotherapy2024-07-1611 citations